Back to Search Start Over

566 ENTPD1 as predictive marker of treatment response to gemogenovatucel-T (Vigil) in newly diagnosed ovarian cancer

Authors :
Rodney Rocconi
Laura Stanbery
Min Tang
Adam Walter
Bradley Monk
Thomas Herzog
Robert Coleman
Luisa Manning
Gladice Wallraven
Staci Horvath
Ernest Bognar
Neil Senzer
Scott Brun
John Nemunaitis
Source :
Regular and Young Investigator Award Abstracts.
Publication Year :
2022
Publisher :
BMJ Publishing Group Ltd, 2022.

Details

Database :
OpenAIRE
Journal :
Regular and Young Investigator Award Abstracts
Accession number :
edsair.doi...........727d10f89d4d5812b07637b3e113e061

Tools

Authors Abstract Subjects Details